The Proton Pump Inhibitor, Omeprazole, but not Lansoprazole or Pantoprazole, is a Metabolism-dependent Inhibitor of CYP2C19: Implications for Coadministration with Clopidogrel Publication The Proton Pump Inhibitor, Omeprazole, but not Lansoprazole or Pantoprazole, is a Metabolism-dependent Inhibitor of CYP2C19: Implications for Coadministration with Clopidogrel As a direct-acting inhibitor of CYP2C19 in vitro, lansoprazole is more potent than omeprazole and…CertaraNovember 1, 2011
Determination of Time-dependent Inactivation of CYP3A4 in Cryopreserved Human Hepatocyte and Assessment of Human Drug-drug Interactions Publication Determination of Time-dependent Inactivation of CYP3A4 in Cryopreserved Human Hepatocyte and Assessment of Human Drug-drug Interactions Assessment of time-dependent inhibition (TDI), especially CYP3A4, is an important parameter for preclinical and clinical…CertaraNovember 1, 2011
Pharmacokinetics of Voriconazole Administered Concomitantly with Fluconazole and Population-based Simulation for Sequential Use Publication Pharmacokinetics of Voriconazole Administered Concomitantly with Fluconazole and Population-based Simulation for Sequential Use In clinical practice, antifungal therapy may be switched from fluconazole to voriconazole; such sequential use…CertaraNovember 1, 2011
Effect of Different Durations and Formulations of Diltiazem on the Single-dose Pharmacokinetics of Midazolam: How Long Do We Go? Publication Effect of Different Durations and Formulations of Diltiazem on the Single-dose Pharmacokinetics of Midazolam: How Long Do We Go? Understanding how inhibition of cytochrome P4503A (CYP3A) affects the metabolism of a new drug is…CertaraNovember 1, 2011
Prediction of Drug-drug Interactions Arising from Mechanism-based Inactivation: Key Input Parameters and Impact on Risk Assessment Publication Prediction of Drug-drug Interactions Arising from Mechanism-based Inactivation: Key Input Parameters and Impact on Risk Assessment As the prevalence of polypharmacy increases with our aging population, the propensity for adverse drug-drug…CertaraNovember 1, 2011
What is Hysteresis in PK/PD Analysis? Knowledge Base What is Hysteresis in PK/PD Analysis? I apologize to all my readers for such a long lapse between posts. After a…CertaraOctober 26, 2011
Safety and Population Pharmacokinetic Analysis of Intravenous Acetaminophen in Neonates, Infants, Children, and Adolescents with Pain or Fever Publication Safety and Population Pharmacokinetic Analysis of Intravenous Acetaminophen in Neonates, Infants, Children, and Adolescents with Pain or Fever The administration of acetaminophen via the oral and rectal routes may be contraindicated in specific…CertaraOctober 16, 2011
Risk Assessment of Accidental Nortriptyline Poisoning: The Importance of Cytochrome P450 for Nortriptyline Elimination Investigated Using a Population-based Pharmacokinetic Simulator Publication Risk Assessment of Accidental Nortriptyline Poisoning: The Importance of Cytochrome P450 for Nortriptyline Elimination Investigated Using a Population-based Pharmacokinetic Simulator It is not possible to make a prospective clinical study that reveals the importance of…CertaraOctober 9, 2011
Evaluation of Combined Bevacizumab and Intraperitoneal Carboplatin or Paclitaxel Therapy in a Mouse Model of Ovarian Cancer Publication Evaluation of Combined Bevacizumab and Intraperitoneal Carboplatin or Paclitaxel Therapy in a Mouse Model of Ovarian Cancer The purpose of this was to evaluate the pharmacokinetics of bevacizumab following IP and IV…CertaraOctober 1, 2011
Pharmacokinetics of SN2310, an Injectable Emulsion that Incorporates a New Derivative of SN-38 in Patients with Advanced Solid Tumors Publication Pharmacokinetics of SN2310, an Injectable Emulsion that Incorporates a New Derivative of SN-38 in Patients with Advanced Solid Tumors SN2310 is an injectable emulsion composed of vitamin E, a succinate derivative, as well as…CertaraOctober 1, 2011